Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with hormone receptor-positive (HR-positive) invasive breast cancer.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who were found to have cancer that had spread to the brain either at the time of their breast cancer diagnosis or within the first three months after diagnosis.
- People who have cancer in both breasts.
- People who have a second, separate cancer diagnosed at the same time, such as lung cancer or melanoma.
- People who have neurological symptoms (such as issues affecting the brain or nervous system) but have not had follow-up care or have not had a contrast-enhanced MRI scan (a detailed brain scan using dye to highlight abnormalities). (confirm with trial site)
- People whose medical and pathology records from the time of diagnosis are incomplete.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201092655523
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Validity of prediction model of brain metastases risk for females with HR+ breast cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.